We were founded to bring clarity, evidence, and real scientific progress to hair loss care.
Pattern hair loss is a medical condition that deserves rigorous evidence, validated therapies, and clear guidance for patients. It’s time to change that.
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company developing innovative therapeutics for pattern hair loss. We are currently developing investigational product, VDPHL01:
- Designed to be the first oral, non-hormonal FDA-approved therapy for pattern hair loss in men and women.
- Evaluated through the rigorous, large-scale, placebo-controlled clinical trials designed to assess safety and efficacy.
Not an actual patient
Our mission
To set a new standard in pattern hair loss by developing therapies rooted in rigorous clinical evidence.
Recent news
Pattern hair loss deserves more.
A profound unmet need
Pattern hair loss transcends mere aesthetics. It’s deeply personal, psychological, and essentially universal, yet the standard of care has not meaningfully changed in decades.
Not an actual patient
Deep roots
Our seasoned management team has long-term experience in dermatology and the pattern hair loss community.
Advancing clinical research
Three Phase 3 clinical trials underway in pattern hair loss, marking the first Phase 3 trials for an oral therapy in nearly 30 years and the first ever in the U.S. for female pattern hair loss.